Kwality Pharmaceuticals Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 780.95 million compared to INR 562.03 million a year ago. Revenue was INR 787.13 million compared to INR 565.54 million a year ago. Net income was INR 76.9 million compared to INR 71 million a year ago. Basic earnings per share from continuing operations was INR 7.39 compared to INR 6.82 a year ago. Diluted earnings per share from continuing operations was INR 7.39 compared to INR 6.82 a year ago.
For the nine months, sales was INR 2,151.95 million compared to INR 1,822.26 million a year ago. Revenue was INR 2,164.42 million compared to INR 1,837.07 million a year ago. Net income was INR 193.49 million compared to INR 267.51 million a year ago. Basic earnings per share from continuing operations was INR 18.47 compared to INR 25.38 a year ago. Diluted earnings per share from continuing operations was INR 18.47 compared to INR 25.38 a year ago.